nexplasmagen | NexPlasmaGen

-1

archive,paged,author,author-nexplasmagen,author-2,paged-2,author-paged-2,bridge-core-2.6.4,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-24.9,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-wpml-enabled,wpb-js-composer js-comp-ver-7.7,vc_responsive

Author: nexplasmagen

30 Jan NexPlasmaGen to present at the 2022 OBIO investment summit

Posted at 23:59h in Blog 0 Comments

0 Likes

NEXPLASMAGEN TO PRESENT AT THE 2022 OBIO INVESTMENT SUMMIT Canada’s Premier Health Science Investment Event! Montreal/January 30, 2022 – NexPlasmaGen is proud to announce that it is presenting at 2022 OBIO Investment Summit. The OBIO Investment Summit will be hosted virtually February 9-11, 2022, and NexPlasmaGen was selected...

Author: nexplasmagen

30 Jan NexPlasmaGen to present at the 2022 OBIO investment summit

London, UK Offices